272 related articles for article (PubMed ID: 23172614)
1. Multiparametric MRI for prostate cancer localization in correlation to whole-mount histopathology.
Isebaert S; Van den Bergh L; Haustermans K; Joniau S; Lerut E; De Wever L; De Keyzer F; Budiharto T; Slagmolen P; Van Poppel H; Oyen R
J Magn Reson Imaging; 2013 Jun; 37(6):1392-401. PubMed ID: 23172614
[TBL] [Abstract][Full Text] [Related]
2. Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging.
Hoeks CM; Hambrock T; Yakar D; Hulsbergen-van de Kaa CA; Feuth T; Witjes JA; Fütterer JJ; Barentsz JO
Radiology; 2013 Jan; 266(1):207-17. PubMed ID: 23143029
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
4. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
[TBL] [Abstract][Full Text] [Related]
5. Is there an additional value of ¹¹C-choline PET-CT to T2-weighted MRI images in the localization of intraprostatic tumor nodules?
Van den Bergh L; Koole M; Isebaert S; Joniau S; Deroose CM; Oyen R; Lerut E; Budiharto T; Mottaghy F; Bormans G; Van Poppel H; Haustermans K
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1486-92. PubMed ID: 22284686
[TBL] [Abstract][Full Text] [Related]
6. Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging--initial experience.
Lin G; Ng KK; Chang CJ; Wang JJ; Ho KC; Yen TC; Wu TI; Wang CC; Chen YR; Huang YT; Ng SH; Jung SM; Chang TC; Lai CH
Radiology; 2009 Mar; 250(3):784-92. PubMed ID: 19244045
[TBL] [Abstract][Full Text] [Related]
7. Multiparametric Magnetic Resonance Imaging of the Prostate for Tumour Detection and Local Staging: Imaging in 1.5T and Histopathologic Correlation.
Loggitsi D; Gyftopoulos A; Economopoulos N; Apostolaki A; Kalogeropoulos T; Thanos A; Alexopoulou E; Kelekis NL
Can Assoc Radiol J; 2017 Nov; 68(4):379-386. PubMed ID: 28720413
[TBL] [Abstract][Full Text] [Related]
8. Correlation of quantitative diffusion-weighted and dynamic contrast-enhanced MRI parameters with prognostic factors in prostate cancer.
Chung MP; Margolis D; Mesko S; Wang J; Kupelian P; Kamrava M
J Med Imaging Radiat Oncol; 2014 Oct; 58(5):588-94. PubMed ID: 25196228
[TBL] [Abstract][Full Text] [Related]
9. Volumetry of the dominant intraprostatic tumour lesion: intersequence and interobserver differences on multiparametric MRI.
Harvey H; Orton MR; Morgan VA; Parker C; Dearnaley D; Fisher C; deSouza NM
Br J Radiol; 2017 Mar; 90(1071):20160416. PubMed ID: 28055249
[TBL] [Abstract][Full Text] [Related]
10. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM
AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293
[TBL] [Abstract][Full Text] [Related]
11. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
[TBL] [Abstract][Full Text] [Related]
12. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.
Haider MA; Chung P; Sweet J; Toi A; Jhaveri K; Ménard C; Warde P; Trachtenberg J; Lockwood G; Milosevic M
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):425-30. PubMed ID: 17881141
[TBL] [Abstract][Full Text] [Related]
13. Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade.
Takeuchi M; Sasaki S; Ito M; Okada S; Takahashi S; Kawai T; Suzuki K; Oshima H; Hara M; Shibamoto Y
Radiology; 2009 Apr; 251(1):112-21. PubMed ID: 19332849
[TBL] [Abstract][Full Text] [Related]
14. Diffusion-weighted imaging of the prostate: Comparison of b1000 and b2000 image sets for index lesion detection.
Rosenkrantz AB; Hindman N; Lim RP; Das K; Babb JS; Mussi TC; Taneja SS
J Magn Reson Imaging; 2013 Sep; 38(3):694-700. PubMed ID: 23371846
[TBL] [Abstract][Full Text] [Related]
15. Fusion of Magnetic Resonance Imaging and Real-Time Elastography to Visualize Prostate Cancer: A Prospective Analysis using Whole Mount Sections after Radical Prostatectomy.
Brock M; Roghmann F; Sonntag C; Sommerer F; Tian Z; Löppenberg B; Palisaar RJ; Noldus J; Hanske J; von Bodman C
Ultraschall Med; 2015 Aug; 36(4):355-61. PubMed ID: 24854132
[TBL] [Abstract][Full Text] [Related]
16. Comparison of real-time elastography and multiparametric MRI for prostate cancer detection: a whole-mount step-section analysis.
Junker D; Schäfer G; Kobel C; Kremser C; Bektic J; Jaschke W; Aigner F
AJR Am J Roentgenol; 2014 Mar; 202(3):W263-9. PubMed ID: 24555623
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric MRI is helpful to predict tumor focality, stage, and size in patients diagnosed with unilateral low-risk prostate cancer.
Delongchamps NB; Beuvon F; Eiss D; Flam T; Muradyan N; Zerbib M; Peyromaure M; Cornud F
Prostate Cancer Prostatic Dis; 2011 Sep; 14(3):232-7. PubMed ID: 21423266
[TBL] [Abstract][Full Text] [Related]
18. Histology core-specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate.
Kuru TH; Roethke MC; Rieker P; Roth W; Fenchel M; Hohenfellner M; Schlemmer HP; Hadaschik BA
BJU Int; 2013 Dec; 112(8):1080-7. PubMed ID: 23937255
[TBL] [Abstract][Full Text] [Related]
19. Does 11C-choline PET-CT contribute to multiparametric MRI for prostate cancer localisation?
Van den Bergh L; Isebaert S; Koole M; Oyen R; Joniau S; Lerut E; Deroose CM; De Keyzer F; Van Poppel H; Haustermans K
Strahlenther Onkol; 2013 Sep; 189(9):789-95. PubMed ID: 23797481
[TBL] [Abstract][Full Text] [Related]
20. Detection of locally radio-recurrent prostate cancer at multiparametric MRI: Can dynamic contrast-enhanced imaging be omitted?
Alonzo F; Melodelima C; Bratan F; Vitry T; Crouzet S; Gelet A; Rouvière O
Diagn Interv Imaging; 2016 Apr; 97(4):433-41. PubMed ID: 26928245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
